Randomized comparative clinical study of vajigandhadi taila matra basti and pana in the management of gridhrasi w.s.r lumbosacral radiculopathy
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Only objective parameters will be employed for the assessment of the impact of treatment procedures in the respective group.
Study Overview
Brief Summary
Trial is going on..
Study Design
- Study Type
- Interventional
- Allocation
- Computer generated randomization
- Masking
- Not Applicable
Eligibility Criteria
- Ages
- 25.00 Year(s) to 65.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Daignosed cases of gridhrasi(lumbosacral radiculopathy) Patient daiagnosed of lumbago based upon investigation History of lumbosal sprain/strain/ lumbago for more than six months.
Exclusion Criteria
- •Uncontrolled diabetes mellitus Uncontrolled T.B.of spine & hip joint Uncontrolled hypertention Malignancy of spine or other or organs Fracture related to spine Cardiac disease(IHD, CAD, MI etc) Anaemic(Hb% less than 7.00 mg/dl) Pregnancy Age group less than 20 years and greater than 60 years Refferred low backache from pelvis, abdomen or thoracic disease.
Outcomes
Primary Outcomes
Only objective parameters will be employed for the assessment of the impact of treatment procedures in the respective group.
Time Frame: Only objective parameters will be employed for the assessment of the impact of treatment procedures in the respective group. | Complete remission-100% | Markedly improved-76-99% | Moderately improved-51-75% | Improved - 26-50% | Unchanged - 0-25%
Moderately improved-51-75%
Time Frame: Only objective parameters will be employed for the assessment of the impact of treatment procedures in the respective group. | Complete remission-100% | Markedly improved-76-99% | Moderately improved-51-75% | Improved - 26-50% | Unchanged - 0-25%
Improved - 26-50%
Time Frame: Only objective parameters will be employed for the assessment of the impact of treatment procedures in the respective group. | Complete remission-100% | Markedly improved-76-99% | Moderately improved-51-75% | Improved - 26-50% | Unchanged - 0-25%
Complete remission-100%
Time Frame: Only objective parameters will be employed for the assessment of the impact of treatment procedures in the respective group. | Complete remission-100% | Markedly improved-76-99% | Moderately improved-51-75% | Improved - 26-50% | Unchanged - 0-25%
Unchanged - 0-25%
Time Frame: Only objective parameters will be employed for the assessment of the impact of treatment procedures in the respective group. | Complete remission-100% | Markedly improved-76-99% | Moderately improved-51-75% | Improved - 26-50% | Unchanged - 0-25%
Markedly improved-76-99%
Time Frame: Only objective parameters will be employed for the assessment of the impact of treatment procedures in the respective group. | Complete remission-100% | Markedly improved-76-99% | Moderately improved-51-75% | Improved - 26-50% | Unchanged - 0-25%
Secondary Outcomes
- Excerbation in sign & symptoms(42 days)